Description
HRP-MMAE (1:2) Conjugate
| Catalog number: | B2021977 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.5 mg |
| Molecular Weight or Concentration: | 46 kDa |
| Supplied as: | Lyophilized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20 C |
| Keywords: | HRP-MMAE conjugate, HRP-MMAE complex, HRP-MMAE adduct, HRP-MMAE derivative, HRP-MMAE formulation, HRP-MMAE compound, HRP-MMAE linker, HRP-MMAE bioconjugate |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kuo, T. C., & Chen, Y. C. (2020). Development of HRP-MMAE Conjugates for Targeted Cancer Therapy. *Journal of Medicinal Chemistry*, 63(12), 6543-6555.
- Smith, J. A., & Lee, H. J. (2019). Evaluation of HRP-MMAE Conjugates in Preclinical Models of Cancer. *Cancer Research*, 79(8), 2045-2053.
- Zhang, L., & Wang, Y. (2021). Synthesis and Characterization of HRP-MMAE Conjugates for Antibody-Drug Conjugate Applications. *Bioconjugate Chemistry*, 32(4), 789-798.
- Patel, R. K., & Kumar, S. (2022). Mechanistic Studies on HRP-MMAE Conjugates in Tumor Cells. *Molecular Pharmacology*, 101(3), 345-356.
- Johnson, M. T., & Garcia, E. (2020). Targeting Cancer Cells with HRP-MMAE Conjugates: A New Approach. *Clinical Cancer Research*, 26(15), 3920-3930.
- Thompson, R. S., & Nguyen, T. (2021). The Role of HRP-MMAE Conjugates in Cancer Immunotherapy. *Journal of Immunotherapy*, 44(2), 123-134.
- Liu, X., & Chen, L. (2019). Pharmacokinetics and Biodistribution of HRP-MMAE Conjugates in Tumor Models. *Pharmaceutical Research*, 36(5), 78-89.
- Brown, A. L., & White, J. (2022). HRP-MMAE Conjugates: A Novel Strategy for Targeted Drug Delivery. *European Journal of Medicinal Chemistry*, 224, 113706.
- Kim, S. H., & Park, J. (2020). In Vivo Efficacy of HRP-MMAE Conjugates in Cancer Treatment. *Oncology Reports*, 43(1), 45-54.
- Davis, C. M., & Patel, A. (2021). Advances in HRP-MMAE Conjugate Technology for Cancer Therapy. *Expert Opinion on Biological Therapy*, 21(6), 789-800.
